Novavax lags behind other drugmakers in the global race for COVID-19 vaccine, with shots from Pfizer and Moderna authorized for emergency use in the United States. Novavax announced on Monday that it is ready to start recruiting 30,000 volunteers in the U.S. and Mexico to its late-stage trial of its coronavirus vaccine (file)Novavax has signed supply agreements with several countries and is set to provide 60 million doses to the UK, where a late-stage study is under way. Instead of randomly giving half the participants that vaccine and half the placebo, Novavax will give real shots to two-thirds of participants. The firm also promised not to prevent participants from getting authorized vaccines if they become eligible for them. Novavax is also running a fully enrolled Phase 2b trial in South Africa and a Phase 1/2 continuation in the United States and Australia.

Source: Daily Mail December 28, 2020 19:28 UTC